ABBV stock news
This page provides real-time market news, earnings updates, and company announcements related to AbbVie Inc. (ABBV).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-10 22:06 EST
Is ANIP Priced Below Its True Value? Understanding Its Forward P/E Ratio of 9.3x
101 finance2026-03-31 17:24:59
ABBV Options Display Bullish Bias Between $220 and $225: A Trading Strategy for March 31, 2026
101 finance2026-03-31 18:30:59
PFE Shares Remain Above 200 & 50-Day Moving Averages for 3 Months: Strategies to Consider
101 finance2026-04-01 16:30:54
AbbVie Stock Slides Amid Earnings Uncertainty and Competitive Pressures Despite Leading Trading Volume
101 finance2026-04-01 22:36:43
Aldeyra's Triple-Dip Sell-Off Generates Alpha: Emotional Reactions Undervalue Both Cash and Options
101 finance2026-04-02 22:12:54
AbbVie’s April 29 Earnings Test: Can It Defend Growth Amid Oral Drug Threats?
101 finance2026-04-03 14:52:04
AbbVie announced its full-year financial guidance for 2026
老虎证券2026-04-03 20:17:31
The Top Dividend ETF to Consider Purchasing in April 2026 for Generating Passive Income
101 finance2026-04-05 20:12:48
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Finviz2026-04-06 11:03:56
How might Skyrizi and Rinvoq influence AbbVie's immunology sales in the first quarter?
101 finance2026-04-06 13:18:46
ABBV Options Signal Faces Crucial Test at $205–210 as Market Participants Balance Immediate Risk Against Range-Bound Strategies
101 finance2026-04-06 18:30:51
AbbVie (ABBV) Shares Decline Even as Market Rises: Key Points to Consider
101 finance2026-04-06 22:49:02
Terns investors believe Merck’s $53 acquisition offer undervalues the company—arbitrage involves the possibility of competing bids or the deal falling through
101 finance2026-04-07 13:28:02
AbbVie’s Reduced Earnings Outlook Overshadowed by Over $30 Billion Growth Engine in Immunology
101 finance2026-04-08 04:06:45
AtaiBeckley's BPL-003 May Lay the Foundation for a Scalable Mental Health System—The Outcome of 2026 Phase 3 Studies Will Determine Its Future
101 finance2026-04-08 10:24:56
AbbVie's Skyrizi and Rinvoq Surge: Market Underestimates 2026 Growth Catalyst
101 finance2026-04-08 15:00:48
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
101 finance2026-04-08 19:21:43
PhRMA's Leadership Changes as Industry Divisions Widen and Price Disputes Intensify
101 finance2026-04-08 19:42:41
Nxera Pharma’s $1.2B Milestone Deal with AbbVie Depends on Upcoming Performance
101 finance2026-04-09 00:00:55
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Finviz2026-04-09 12:03:53
ABBV: Call Open Interest Soars at $230 as Legal and Earnings Moves Shape the Path Forward
101 finance2026-04-09 18:34:15
Battle of Big Pharma: Is AbbVie Outperforming Pfizer in the Stock Market?
101 finance2026-04-10 14:39:35
Analysts Love JBVIO, but Cash Flows Tell a Cautious Story
101 finance2026-04-11 00:21:51
Ocular Rallies 15% as Big Money Sells Out
101 finance2026-04-11 01:09:44
Aldeyra's Triple-Dip Sell-Off Generates Alpha: Emotional Reactions Undervalue Both Cash and Options
101 finance2026-04-02 22:12:54
AbbVie’s April 29 Earnings Test: Can It Defend Growth Amid Oral Drug Threats?
101 finance2026-04-03 14:52:04
AbbVie announced its full-year financial guidance for 2026
老虎证券2026-04-03 20:17:31
The Top Dividend ETF to Consider Purchasing in April 2026 for Generating Passive Income
101 finance2026-04-05 20:12:48
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Finviz2026-04-06 11:03:56
How might Skyrizi and Rinvoq influence AbbVie's immunology sales in the first quarter?
101 finance2026-04-06 13:18:46
ABBV Options Signal Faces Crucial Test at $205–210 as Market Participants Balance Immediate Risk Against Range-Bound Strategies
101 finance2026-04-06 18:30:51
AbbVie (ABBV) Shares Decline Even as Market Rises: Key Points to Consider
101 finance2026-04-06 22:49:02
Terns investors believe Merck’s $53 acquisition offer undervalues the company—arbitrage involves the possibility of competing bids or the deal falling through
101 finance2026-04-07 13:28:02
AbbVie’s Reduced Earnings Outlook Overshadowed by Over $30 Billion Growth Engine in Immunology
101 finance2026-04-08 04:06:45
AtaiBeckley's BPL-003 May Lay the Foundation for a Scalable Mental Health System—The Outcome of 2026 Phase 3 Studies Will Determine Its Future
101 finance2026-04-08 10:24:56
AbbVie's Skyrizi and Rinvoq Surge: Market Underestimates 2026 Growth Catalyst
101 finance2026-04-08 15:00:48
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
101 finance2026-04-08 19:21:43
PhRMA's Leadership Changes as Industry Divisions Widen and Price Disputes Intensify
101 finance2026-04-08 19:42:41
Nxera Pharma’s $1.2B Milestone Deal with AbbVie Depends on Upcoming Performance
101 finance2026-04-09 00:00:55
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Finviz2026-04-09 12:03:53
ABBV: Call Open Interest Soars at $230 as Legal and Earnings Moves Shape the Path Forward
101 finance2026-04-09 18:34:15
Battle of Big Pharma: Is AbbVie Outperforming Pfizer in the Stock Market?
101 finance2026-04-10 14:39:35
Analysts Love JBVIO, but Cash Flows Tell a Cautious Story
101 finance2026-04-11 00:21:51
Ocular Rallies 15% as Big Money Sells Out
101 finance2026-04-11 01:09:44
ABBV stock chart
ABBV stock detailsABBV stock price change
On the last trading day, ABBV stock closed at 212.40 USD, with a price change of 0.38% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more